Related Experiment Videos
[Lithium carbonate augmentation in tricyclic antidepressant-resistant depression]
1Talbieh Mental Health Center, Jerusalem.
Harefuah
|December 1, 1991
Summary
Combining lithium carbonate with tricyclic antidepressants can treat resistant unipolar depression. This case study shows successful treatment of severe depression using lithium carbonate and desipramine in a patient unresponsive to other antidepressants.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Treatment-resistant unipolar depression poses a significant clinical challenge.
- Standard antidepressant monotherapy is often insufficient for severe cases.
Observation:
- A 57-year-old woman with severe unipolar depression exhibited resistance to multiple antidepressant classes.
- Maximal doses of two different classes of antidepressants failed to yield improvement.
Findings:
- The addition of lithium carbonate to a maximal dose of desipramine resulted in rapid and sustained symptom remission.
- This combination therapy proved effective where previous treatments had failed.
Implications:
- Lithium augmentation may be a viable strategy for select patients with treatment-resistant depression.
- Careful patient selection and monitoring are essential when considering lithium-tricyclic antidepressant combinations.